Silexion Therapeutics Ltd. (SLXN) Options Chain

The options chain displays all available contracts with end-of-day quotes, Greeks, volume, and open interest for each strike and expiration, and streams live quotes for traders who connect a broker. It is the primary tool for options trade selection.

Silexion Therapeutics Ltd. (SLXN) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $73,743, listed on NASDAQ, employing roughly 14 people, carrying a beta of -0.25 to the broader market. Silexion Therapeutics LTD is a biopharmaceutical company specializing in the discovery and advancement of RNA interference (RNAi)-based cancer therapies and their associated delivery systems, with a focus on treating aggressive solid tumors. Led by Ilan Hadar, public since 2024-08-16.

The options chain displays all available contracts with quotes, Greeks, and open interest. No recent options activity for SLXN as of 2026-10-15; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how the options chain is reported and how to read the data →